Publications by authors named "Zonghai Li"

Claim this Profile
I
In-depth plasma proteomics reveals the dynamic changes and prognostic biomarkers for chimeric antigen receptor-glypican-3 T-cell therapy in patients with hepatocellular carcinoma.
Xudong Zhu, Ziliang Yang, Bin Li, Zhou Tong, Junyi Yan, Libin Hong, Lina Meng, Lulu Liu, Zonghai Li, Tingbo Liang

Gastroenterol Rep (Oxf)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial.
Lina Jin, Sinan Gu, Qianqi Ruan, Jing Lu, Wanting Qiang, Jin Liu, Zonghai Li

Lancet Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term Follow-up of Zevor-cel in Patients with Relapsed/Refractory Multiple Myeloma.
Chengcheng Fu, Wenming Chen, Zhen Cai, Lingzhi Yan, Huijuan Wang, Yanling Wen, Zonghai Li

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.
Wenming Chen, Chengcheng Fu, Baijun Fang, Aibin Liang, Zhongjun Xia, Hui Liu, Jing Liu, Yanli Yang, Hong Liu, Zonghai Li

Exp Hematol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer.
Yue Qing, Ke Jiang, Hua Jiang, Yaru Zhao, Chu-Hu Lai, Zonghai Li

Adv Healthc Mater· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial.
Changsong Qi, Chang Liu, Zhi Peng, Yanqiao Zhang, Jia Wei, Ning Li, Tianshu Liu, Anwen Liu, Xiaoyan Lin, Tongyu Lin, Xianglin Yuan, Jian Li, Zonghai Li, Lin Shen

Lancet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer.
Sun Ruixin, Liu Yifan, Sun Yansha, Zhou Min, Dong Yiwei, Hu Xiaoli, Li Zonghai

Br J Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma.
Rui-Xin Sun, Yi-Fan Liu, Yan-Sha Sun, Min Zhou, Yi Wang, Zong-Hai Li

Acta Pharmacol Sin· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.
Gregory P Botta, Joseph Chao, Hong Ma, Michael Hahn, Gloria Sierra, Zonghai Li

J Immunother Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study.
Changsong Qi, Xiaoyi Chong, Ting Zhou, Mingyang Ma, Jifang Gong, Jian Li, Zhen Liu, Zonghai Li, Lin Shen

Chin J Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer.
Ruixin Sun, Yansha Sun, Chuanlong Wu, Yifan Liu, Min Zhou, Zonghai Li

Mol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy.
Yaoping Shi, Donghua Shi, Jiachang Chi, Dan Cui, Xiaoyin Tang, Yan Lin, Zonghai Li

Cancer Commun (Lond)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.
Qihan Fu, Yi Zheng, Weijia Fang, Qingwei Zhao, Peng Zhao, Lulu Liu, Meihua Lin, Zhen Liu, Zonghai Li, Tingbo Liang

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461.
Sun Ruixin, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Liu Zhengyang, Fan Mingliang, Li Zonghai

Biochem Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer.
Sun Ruixin, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Liu Zhengyang, Fan Mingliang, Li Zonghai

Biochem Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer.
Yifan Liu, Yansha Sun, Peng Wang, Songling Li, Yiwei Dong, Zonghai Li

J Transl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death.
Yi Wang, Honghong Zhang, Guoxiu Du, Hong Luo, Jingwen Su, Henry Q X Li, Zonghai Li

Mol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signaling.
Min Zhou, Muhua Chen, Bizhi Shi, Shengmeng Di, Ruixin Sun, Zonghai Li

Mol Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
Hongwei Sun, Chongyun Xing, Songfu Jiang, Kang Yu, Shengjie Dai, Zonghai Li

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials.
Min Yang, Wenhao Zhang, Kang Yu, Peng Wang, Hua Jiang, Linjun Chen, Lihui Dai, Zonghai Li

Haematologica· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.
Changsong Qi, Jifang Gong, Jian Li, Dan Liu, Yanru Qin, Zhen Liu, Zonghai Li, Lin Shen

Nat Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors.
Yansha Sun, Yiwei Dong, Ruixin Sun, Yifan Liu, Yi Wang, Zonghai Li

Mol Ther Oncolytics· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice.
Ruixin Sun, Hong Luo, Jingwen Su, Shengmeng Di, Min Zhou, Zonghai Li

Mol Ther· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion.
Hong Luo, Jingwen Su, Ruixin Sun, Yansha Sun, Yi Wang, Zonghai Li

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRCH1 deficiency enhances LAT signalosome formation and CD8 T cell responses against tumors and pathogens.
Chang Liu, Xiaoyan Xu, Lei Han, Xiaopeng Wan, Lingming Zheng, Chunyang Li, Zhaohui Liao, Zonghai Li

Proc Natl Acad Sci U S A· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis